Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib

Autor: Sharaf B, Abu-Fares H, Tamimi F, Al-Sawajneh S, Salama O, Daoud R, Alhajahjeh A, Al-Lababidi S, Abdel-Razeq H

Publikováno v: Breast Cancer: Targets and Therapy, Vol Volume 15, Pp 541-548 (2023)

Baha’ Sharaf, Hala Abu-Fares, Faris Tamimi, Suhaib Al-Sawajneh, Osama Salama, Rand Daoud, Abdulrahman Alhajahjeh, Sawsan Al-Lababidi, Hikmat Abdel-Razeq Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanCorrespondence: Hikma

Externí odkaz: https://doaj.org/article/aa9b31a51b76433088c34c69d96d1fd9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.

Autor: Halahleh K; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan. Electronic address: Kh.06314@khcc.jo., Al Sawajneh S; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Saleh Y; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Shahin O; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Abufara A; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Ma'koseh M; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Abdel-Razeq R; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Barakat F; Department of Hematopathology, King Hussein Cancer Center, Amman, Jordan., Abdelkhaleq H; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan., Al-Hassan N; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Atiyyat R; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Al-Faker N; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Omari Z; Department of Radiology, King Hussein Cancer Center, Amman, Jordan., Ghatasheh H; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan., Jaradat I; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan., Muradi I; Department of Medicine, University of Tripoli, Tripoli, Libya., Iyad S; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan., Bazarbachi A; Bone Marrow Transplantation Department, American University of Beirut, Beirut, Lebanon.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. 589-595. Date of Electronic Publication: 2022 Mar 04.